A comparative pharmaco-metabolomic study of glutaminase inhibitors in glioma stem-like cells confirms biological effectiveness but reveals differences in target-specificity
Katharina Koch(Düsseldorf University Hospital), Ulf D. Kahlert(University Hospital Magdeburg)
Cited by 89
Related Papers
BRAF Activation Induces Transformation and Then Senescence in Human Neural Stem Cells: A Pilocytic Astrocytoma Model
|Clinical Cancer Research|2011|202
LIN28A facilitates the transformation of human neural stem cells and promotes glioblastoma tumorigenesis through a pro-invasive genetic program
|Oncotarget|2013|73
DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with <i>In Silico</i> Analysis to Identify Novel Therapeutic Targets
|Clinical Cancer Research|2016|68
ZEB1 Promotes Invasion in Human Fetal Neural Stem Cells and Hypoxic Glioma Neurospheres
|Brain Pathology|2014|64
An immunocompetent mouse model of human glioblastoma
|Oncotarget|2017|52